<DOC>
	<DOCNO>NCT03025139</DOCNO>
	<brief_summary>This randomized phase III trial study well mindfulness meditation survivorship education work improve behavioral symptom young stage 0-III breast cancer survivor . Behavioral intervention , mindfulness meditation , use technique help patient change way react environmental trigger may cause negative reaction . Survivorship education treatment may reduce stress improve well-being quality life patient breast cancer . Mindfulness meditation survivorship education may help improve health behavior young breast cancer survivor .</brief_summary>
	<brief_title>Mindfulness Meditation Survivorship Education Improving Behavioral Symptoms Younger Stage 0-III Breast Cancer Survivors ( Pathways Wellness )</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate efficacy two different type group intervention ( mindfulness survivorship education ) , specifically tailor need young female breast cancer survivor , reduce depressive symptom , compare usual care control group . SECONDARY OBJECTIVES : I . To compare efficacy two intervention relative usual care control group fatigue , sleep disturbance , vasomotor symptom . II . To examine efficacy two intervention relative usual care control group circulate genomic marker inflammation . III . To explore potential moderator mediator intervention efficacy two intervention group . OUTLINE : Patients randomize 1 3 arm . ARM A ( MINDFULNESS AWARENESS PRACTICES [ MAPs ] ) : Patients attend mindfulness meditation class 2 hour weekly 6 week . Patients attend person booster session include guided meditation , question , discussion maintain mindfulness practice 1 hour monthly 3 month . ARM B ( SURVIVORSHIP EDUCATION INTERVENTION [ SE ] ) : Patients attend survivorship education class 2 hour weekly 6 week . Patients also receive monthly electronic newsletter tailor information topic interest young survivor , include cancer-related event community tip follow recommendation healthy living . ARM C ( USUAL CARE/DELAYED TREATMENT CONTROL GROUP ) : Patients receive usual care 9 month . Patients offer choice participate Arm A Arm B . After completion study , patient follow 3 6 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Behavioral Symptoms</mesh_term>
	<criteria>Women diagnose early stage , resectable breast cancer ( Stage 0 , I , II , III ) prior age 45 , within 5 year diagnosis Have complete surgery , radiation , and/or chemotherapy treatment least 6 month previously ; may still receive trastuzumab endocrine adjuvant therapy Ability complete evaluation survey English Have evidence least mild clinical depression standardize screen questionnaire Has breast cancer recurrence , metastasis , another interval cancer diagnosis follow breast cancer ( exclude nonmelanoma skin cancer ) Unable commit intervention schedule ( 6 weekly group meeting ) Actively practice mindfulness meditation Has another serious chronic medical psychiatric condition contribute substantial physical emotional disability would detract participate either intervention program measurement intervention outcome</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>young woman</keyword>
	<keyword>education</keyword>
	<keyword>mindfulness meditation</keyword>
	<keyword>depression</keyword>
	<keyword>cancer survivor</keyword>
</DOC>